Patients and methods: A cross-sectional descriptive retrospective and prospective, on 33 patients with progressive, recurrent, metastatic were treated with Paclitaxel-Carboplatin plus Bevacizumab in Hanoi Oncology Hospital from October 2018 to June 2021.